Abiopharma

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm

Smith+Nephew PLC Notification

3 SEPTEMBRE 2025

BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected

New Form SCHEDULE 13D - Shattuck Labs, Inc. Filed: 2025-09-02 AccNo: 0000947871-25-000841 Size: 30 KB

Director ORBIMED ADVISORS LLC 🟢 acquired 36.9M shares (4 derivative) of Shattuck Labs, Inc. (STTK) at $1.08 ($25.5M) Transaction Date: Aug 25, 2025 | Filing ID: 000840

Director Ashiya Mona 🟢 acquired 36.9M shares (4 derivative) of Shattuck Labs, Inc. (STTK) at $1.08 ($25.5M) Transaction Date: Aug 25, 2025 | Filing ID: 000839

New Form 3 - Shattuck Labs, Inc. Filed: 2025-09-02 AccNo: 0000947871-25-000838 Size: 6 KB

RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Dizon Romeo R 🟢 acquired 625 shares of IRIDEX CORP (IRIX) at $1.34 Transaction Date: Sep 02, 2025 | Filing ID: 112648

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock